Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_3
1
17%
Ph not_applicable
2
33%
Ph phase_4
1
17%
Ph phase_2
2
33%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Terminated(1)

Detailed Status

Completed5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (33.3%)
Phase 31 (16.7%)
Phase 41 (16.7%)
N/A2 (33.3%)

Trials by Status

completed583%
terminated117%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_2

A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3

NCT00000771
completedphase_2

Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia

NCT03096457
terminatednot_applicable

Treatment of Chronic Cryptosporidiosis in AIDS Patients

NCT00001128
completedphase_4

Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis

NCT00604955
completedphase_3

Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis

NCT00216346
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00000771Phase 2

A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3

Completed
NCT03096457Phase 2

Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia

Completed
NCT00001128Not Applicable

Treatment of Chronic Cryptosporidiosis in AIDS Patients

Terminated
NCT00604955Phase 4

Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis

Completed
NCT00216346Phase 3

Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis

Completed
NCT01328457Not Applicable

An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6